Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8987237 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US10639375 | THERAPEUTICSMD INC | Progesterone formulations |
Nov, 2032
(9 years from now) | |
US11110099 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US8993548 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US11103516 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US10206932 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US8846649 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US8846648 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US9114146 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US9114145 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US10675288 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US9301920 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US11033626 | THERAPEUTICSMD INC | Progesterone formulations having a desirable pk profile |
Nov, 2032
(9 years from now) | |
US9006222 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US10806740 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US11103513 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US8933059 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US11166963 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US8633178 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) | |
US10052386 | THERAPEUTICSMD INC | Progesterone formulations |
Nov, 2032
(9 years from now) | |
US8993549 | THERAPEUTICSMD INC | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) |
Market Authorisation Date: 28 October, 2018
Treatment: Treatment of menopause symptoms, including vasomotor symptoms
Dosage: CAPSULE;ORAL
97
United States
20
Australia
18
Japan
13
European Union
11
Korea, Republic of
11
Canada
10
Mexico
8
Russia
8
Brazil
5
Argentina
4
Israel
2
Spain
2
Croatia
2
Hungary
2
Poland
1
Portugal
1
South Africa
1
Lithuania
1
RS
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11529360 | MAYNE PHARMA | Natural combination hormone replacement formulations and therapies |
Nov, 2032
(9 years from now) |
Market Authorisation Date: 28 October, 2018
Treatment: NA
Dosage: CAPSULE;ORAL
92
United States
19
Australia
17
Japan
12
European Union
10
Korea, Republic of
10
Canada
9
Mexico
8
Brazil
7
Russia
4
Argentina
4
Israel
2
Spain
2
Croatia
2
Hungary
2
Poland
1
Portugal
1
South Africa
1
Lithuania
1
RS
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic